Wildcard: The Next Nano-X, But With Less Risk

HyperFine is looking to head to public markets with the lofty goal of disrupting the MRI market with the first FDA-approved portable MRI machine. Join Brian Feroldi and Emily Flippen as they break down HyperFine’s roadshow and unpack this recent SPAC. 

Stocks: HealthCor Catalio Acquisition Corp (HCAQ)

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]